| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 18 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 11 |
| NetGPI | no | yes: 0, no: 11 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0016020 | membrane | 2 | 1 |
| GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: E9B2K3
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0003824 | catalytic activity | 1 | 2 |
| GO:0016874 | ligase activity | 2 | 2 |
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_C14_Caspase3-7 | 57 | 61 | PF00656 | 0.432 |
| CLV_PCSK_SKI1_1 | 161 | 165 | PF00082 | 0.430 |
| DOC_CDC14_PxL_1 | 66 | 74 | PF14671 | 0.372 |
| DOC_PP1_RVXF_1 | 159 | 165 | PF00149 | 0.308 |
| DOC_USP7_MATH_1 | 59 | 63 | PF00917 | 0.516 |
| DOC_USP7_MATH_1 | 79 | 83 | PF00917 | 0.414 |
| DOC_WW_Pin1_4 | 36 | 41 | PF00397 | 0.415 |
| DOC_WW_Pin1_4 | 9 | 14 | PF00397 | 0.418 |
| LIG_14-3-3_CanoR_1 | 107 | 116 | PF00244 | 0.481 |
| LIG_FHA_1 | 110 | 116 | PF00498 | 0.330 |
| LIG_FHA_1 | 122 | 128 | PF00498 | 0.356 |
| LIG_FHA_1 | 135 | 141 | PF00498 | 0.425 |
| LIG_LIR_Gen_1 | 117 | 127 | PF02991 | 0.416 |
| LIG_LIR_Nem_3 | 117 | 123 | PF02991 | 0.384 |
| LIG_LIR_Nem_3 | 147 | 153 | PF02991 | 0.347 |
| LIG_LYPXL_L_2 | 149 | 158 | PF13949 | 0.312 |
| LIG_LYPXL_S_1 | 149 | 153 | PF13949 | 0.343 |
| LIG_SH2_GRB2like | 157 | 160 | PF00017 | 0.314 |
| LIG_SH2_STAT3 | 157 | 160 | PF00017 | 0.314 |
| LIG_SH2_STAT5 | 157 | 160 | PF00017 | 0.314 |
| LIG_SH2_STAT5 | 84 | 87 | PF00017 | 0.326 |
| LIG_SH3_3 | 145 | 151 | PF00018 | 0.376 |
| LIG_SUMO_SIM_par_1 | 4 | 12 | PF11976 | 0.467 |
| MOD_DYRK1A_RPxSP_1 | 36 | 40 | PF00069 | 0.380 |
| MOD_GlcNHglycan | 130 | 133 | PF01048 | 0.396 |
| MOD_GlcNHglycan | 41 | 44 | PF01048 | 0.465 |
| MOD_GlcNHglycan | 60 | 64 | PF01048 | 0.385 |
| MOD_GlcNHglycan | 77 | 80 | PF01048 | 0.378 |
| MOD_GSK3_1 | 15 | 22 | PF00069 | 0.544 |
| MOD_GSK3_1 | 71 | 78 | PF00069 | 0.413 |
| MOD_GSK3_1 | 79 | 86 | PF00069 | 0.418 |
| MOD_NEK2_1 | 41 | 46 | PF00069 | 0.571 |
| MOD_NEK2_2 | 151 | 156 | PF00069 | 0.292 |
| MOD_NEK2_2 | 31 | 36 | PF00069 | 0.348 |
| MOD_PIKK_1 | 71 | 77 | PF00454 | 0.292 |
| MOD_PKA_1 | 134 | 140 | PF00069 | 0.469 |
| MOD_PKA_2 | 25 | 31 | PF00069 | 0.411 |
| MOD_ProDKin_1 | 36 | 42 | PF00069 | 0.418 |
| MOD_ProDKin_1 | 9 | 15 | PF00069 | 0.423 |
| TRG_ENDOCYTIC_2 | 150 | 153 | PF00928 | 0.341 |
| TRG_Pf-PMV_PEXEL_1 | 51 | 55 | PF00026 | 0.485 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N1PEH7 | Leptomonas seymouri | 83% | 100% |
| A0A0S4J9U7 | Bodo saltans | 61% | 99% |
| A0A1X0NUN3 | Trypanosomatidae | 68% | 100% |
| A0A3Q8IGM3 | Leishmania donovani | 98% | 100% |
| A0A422N080 | Trypanosoma rangeli | 72% | 100% |
| A4HK60 | Leishmania braziliensis | 92% | 100% |
| A4I7P6 | Leishmania infantum | 98% | 100% |
| D0A9U8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 73% | 100% |
| Q4Q5K3 | Leishmania major | 99% | 100% |
| V5AQT2 | Trypanosoma cruzi | 71% | 68% |